A buyback announcement tells you almost nothing. Whether it was a good use of money depends on the price paid, where the cash came from, and what the company gave up to spend it. This is the checklist we use.
1. Was the price sensible?
The only way a buyback adds value for remaining holders is if the company pays less than the shares are worth. Compare the average price paid (companies disclose it quarterly) with the valuation at the time: earnings yield, free-cash-flow yield, price to book for banks. A company buying back at 40 times earnings needs heroic growth to justify it. One buying at 8 times earnings barely needs growth at all.
2. Did the share count actually fall?
Gross repurchases are the press-release number. The share count is the truth. If a company spent 3% of its market value on buybacks and the share count fell 1%, two thirds of the money went to offsetting stock issued to employees and in acquisitions. Our company pages show shares outstanding over time and the five-year change. If the line is flat, the buyback is maintenance, not a return of capital.
3. Where did the cash come from?
Buybacks ÷ Free cash flow
Repurchases paid from free cash flow after all investment needs are the gold standard. Repurchases funded by borrowing can still make sense when debt is cheap and the shares are cheap, but they shift risk onto the balance sheet. Watch net debt alongside the buyback trend. For banks and insurers, free cash flow is not a meaningful number; look at capital ratios and regulatory approvals instead.
4. Is it consistent or opportunistic?
Both can be fine, but they mean different things. A steady programme year after year signals surplus cash and discipline. A programme that appears only when the share price is depressed signals a management that thinks about value. A programme that appears only when the share price is high, often to offset option exercises, is the worst kind. The fiscal-year chart on each company page makes the pattern visible.
5. Authorisation versus execution
Boards announce authorisations of eye-catching size, sometimes a tenth of the company or more, with no deadline. Check how much was actually spent. A $50 billion authorisation with $4 billion used in two years is a public-relations exercise.
6. What was given up?
Every euro spent on buybacks is a euro not spent on research, capacity, acquisitions or debt reduction. For a mature business with few growth options that is exactly right. For a company whose competitors are investing heavily while it retires shares, it can be a slow surrender. Compare capital expenditure and research spending with peers.
7. Who benefits from the EPS boost?
If executive bonuses are tied to earnings per share, management has a personal incentive to buy back shares regardless of price. Read the remuneration report. Companies that pay on return on invested capital, free cash flow per share or total shareholder return give cleaner incentives. Our guide to buybacks and EPS explains the mechanics.
8. Insider behaviour
A company buying its shares while executives sell theirs is not necessarily sinister, but it is a question to ask. Form 4 filings in the US and director dealings notices in Europe show you who is on which side of the trade.